Search results
Author(s):
Karthiek R Narala
,
Thomas A LaLonde
,
Sohail Hassan
,
et al
Added:
3 years ago
Chronic kidney disease (CKD) affects approximately 26 million people in the US.1 CKD is considered a coronary risk equivalent and also a risk factor for progression of cardiovascular disease (CVD).2 Cardiovascular death rates are 10–30 times higher in dialysis patients than in the general population.3 This increase in CKD patients is multifactorial and is now mainly considered via two pathways:…
View more
Gender Disparities in PAD
Author(s):
Andrea Martinez
,
Jingwen Huang
,
Arash Harzand
Added:
1 month ago
Article
Author(s):
Gurleen Kaur
,
Swati Chand
,
Devesh Rai
,
et al
Added:
1 year ago
Author(s):
Jimmy Kerrigan
,
Timir K Paul
,
Jay Patel
,
et al
Added:
6 months ago
PCI for Chronic Total Occlusion
Author(s):
Giovanni Maria Vescovo
,
Carlo Zivelonghi
,
Benjamin Scott
,
et al
Added:
3 years ago
Article
Author(s):
Hans P Niendorf
,
P Lengsfeld
,
M Bräutigam
Added:
3 years ago
Contrast-induced nephropathy (CIN) in the actual essence of the term refers to renal damage induced by a contrast medium. The ultimate clinical manifestation of CIN is renal failure requiring dialysis, and this article will concentrate on CIN as a clinical outcome. However, transient rises in serum creatinine have been frequently used as a surrogate marker that is suggested to predict renal…
View more
Author(s):
Ahmed M Alabbady
,
Ahmed S Abdul-Al
,
Kimberly A Skelding
Added:
3 years ago
The introduction of percutaneous coronary angioplasty in 1977 by Dr Andreas Grüntzig1 was one of the most remarkable achievements in the cardiology realm, opening the door to numerous advancements in percutaneous coronary interventions (PCIs). Due to advances in PCI techniques over the past four decades, catheters along with four generations of coronary stents have dramatically changed the…
View more
Author(s):
Tasveer Khawaja
,
Scott Janus
,
Sadeer G Al-Kindi
Added:
1 year ago
Author(s):
Ziad A Ali
Added:
1 year ago
BCIS ACI 2023 – Dr Ziad Ali (St Francis Hospital & Heart Center, Roslyn, NY, US) summarises his ACI keynote lecture on intracoronary imaging in acute coronary syndromes. Dr Ali briefly discusses the FLAVOUR trial demonstrated that in patients with with intermediate coronary stenosis, FFR-guided PCI is noninferior to IVUS-guided PCI.
Recorded on-site BCIS ACI 2023, London.
View more
Author(s):
Gregory J Dehmer
Added:
3 years ago
The use of percutaneous coronary intervention (PCI) for coronary artery revascularization has grown considerably since the first balloon angioplasty in 1977. Improvements in equipment and drug therapies plus the development of coronary artery stents have all contributed to the growth of PCI as an alternative to surgical revascularization. Compared with the early days of balloon angioplasty, when…
View more